These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24854503)

  • 1. Does evidence drive pharmacist over-the-counter product recommendations?
    Rutter P; Wadesango E
    J Eval Clin Pract; 2014 Aug; 20(4):425-8. PubMed ID: 24854503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Views of pharmacy graduates and pharmacist tutors on evidence-based practice in relation to over-the-counter consultations: a qualitative study.
    McKee P; Hughes C; Hanna LA
    J Eval Clin Pract; 2015 Dec; 21(6):1040-6. PubMed ID: 25494961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'First, do no harm': factors that influence pharmacists making decisions about over-the-counter medication: a qualitative study in Northern Ireland.
    Hanna LA; Hughes CM
    Drug Saf; 2010 Mar; 33(3):245-55. PubMed ID: 20158288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse.
    Cooper R
    Health Soc Care Community; 2013 May; 21(3):254-62. PubMed ID: 23320510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2013; 9(3):251-62. PubMed ID: 22835710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the theory of planned behaviour to pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medicines.
    Walker A; Watson M; Grimshaw J; Bond C
    Fam Pract; 2004 Dec; 21(6):670-6. PubMed ID: 15520031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does advice from pharmacy staff vary according to the nonprescription medicine requested?
    Kelly FS; Williams KA; Benrimoj SI
    Ann Pharmacother; 2009 Nov; 43(11):1877-86. PubMed ID: 19843841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-to-consumer advertising: Australian pharmacists' experiences with non-prescription medicines.
    Chaar B; Kwong K
    Int J Pharm Pract; 2010 Feb; 18(1):43-50. PubMed ID: 20405595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.
    Shaw JP; Gauld N; Kelly F
    Int J Pharm Pract; 2016 Feb; 24(1):6-12. PubMed ID: 26154432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland.
    Wazaify M; Hughes CM; McElnay JC
    Patient Educ Couns; 2006 Dec; 64(1-3):136-41. PubMed ID: 16431072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public's views on making decisions about over-the-counter medication and their attitudes towards evidence of effectiveness: a cross-sectional questionnaire study.
    Hanna LA; Hughes CM
    Patient Educ Couns; 2011 Jun; 83(3):345-51. PubMed ID: 21440405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist's recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland.
    Pietrusiewicz M; Kopa-Stojak PN; Pawliczak R
    BMC Fam Pract; 2021 Oct; 22(1):216. PubMed ID: 34717562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Issues and Prospects from the OTC Industry vis a vis Pharmaceutical Education and OTC Medicines].
    Nishizawa M
    Yakugaku Zasshi; 2016; 136(7):955-63. PubMed ID: 27374957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
    Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
    Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence.
    Tran S; Calabretto JP; Sorich M
    Int J Pharm Pract; 2013 Dec; 21(6):378-85. PubMed ID: 23517229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' readiness to assess consumers' over-the-counter product selections.
    Taylor J; Berger B; Anderson-Harper H; Grimley D
    J Am Pharm Assoc (Wash); 2000; 40(4):487-94. PubMed ID: 10932457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.